A Clinical, Regulatory & Operational Readiness Self-Assessment for sponsors planning a structural heart or coronary clinical trial in Europe.
Important: This checklist provides a non-binding, informational readiness assessment only. It does not constitute regulatory advice or a conformity assessment under applicable EU regulations.
Entering Europe for a structural heart or coronary clinical trial is a significant milestone. The difference between a smooth study launch and a delayed, resource-intensive one often comes down to preparation.
Evaluate feasibility, site selection, and imaging or endpoint preparedness for structural heart and coronary studies.
Assess MDR alignment, country-specific pathways, ethics timelines, and indemnification considerations.
Review contracting, monitoring strategy, device logistics, long-term follow-up, and local expertise.
Read the criteria under each of the 7 areas, then select the answer that best reflects your current readiness. Maximum score: 21 points.
Strong readiness. This area is addressed, documented, and operationally ready.
Minor gaps remain. Core elements are in place but some details need to be resolved.
Significant gaps exist. This area has been started but is not yet operationally ready.
This area has not yet been formally assessed or planned.
Complete the 5-minute checklist to receive your readiness tier and a per-area breakdown across regulatory, clinical, and operational dimensions.